| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dexamethasone | 19 | 1995 | 150 | 1.200 |
Why?
|
| Depressive Disorder | 26 | 2000 | 621 | 0.970 |
Why?
|
| Psychotic Disorders | 9 | 2003 | 157 | 0.790 |
Why?
|
| Stress Disorders, Post-Traumatic | 8 | 2005 | 1506 | 0.740 |
Why?
|
| Schizophrenia | 6 | 2000 | 206 | 0.520 |
Why?
|
| Warfare | 2 | 2005 | 58 | 0.480 |
Why?
|
| Bipolar Disorder | 13 | 2001 | 307 | 0.470 |
Why?
|
| Combat Disorders | 3 | 2005 | 102 | 0.450 |
Why?
|
| Antipsychotic Agents | 4 | 2003 | 247 | 0.440 |
Why?
|
| Hydrocortisone | 13 | 1988 | 291 | 0.390 |
Why?
|
| Academic Medical Centers | 3 | 2006 | 281 | 0.310 |
Why?
|
| Haloperidol | 4 | 1999 | 95 | 0.270 |
Why?
|
| Apomorphine | 10 | 1984 | 48 | 0.270 |
Why?
|
| Mental Disorders | 8 | 1995 | 659 | 0.270 |
Why?
|
| Panic Disorder | 2 | 1999 | 121 | 0.270 |
Why?
|
| Adjustment Disorders | 1 | 2005 | 9 | 0.260 |
Why?
|
| Adult | 35 | 2005 | 21375 | 0.250 |
Why?
|
| Middle Aged | 29 | 2005 | 21119 | 0.250 |
Why?
|
| Schizophrenic Psychology | 3 | 2000 | 53 | 0.250 |
Why?
|
| Remote Consultation | 1 | 2005 | 50 | 0.250 |
Why?
|
| Humans | 65 | 2006 | 68525 | 0.240 |
Why?
|
| Military Personnel | 2 | 2005 | 220 | 0.240 |
Why?
|
| Veterans Disability Claims | 1 | 2003 | 11 | 0.240 |
Why?
|
| Delusions | 3 | 2000 | 20 | 0.230 |
Why?
|
| Hallucinations | 2 | 2000 | 19 | 0.230 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2005 | 307 | 0.230 |
Why?
|
| Male | 38 | 2005 | 37281 | 0.230 |
Why?
|
| Mental Health Services | 2 | 2005 | 199 | 0.230 |
Why?
|
| Compensation and Redress | 1 | 2003 | 8 | 0.230 |
Why?
|
| Veterans | 4 | 2005 | 904 | 0.230 |
Why?
|
| Prisoners | 1 | 2003 | 50 | 0.220 |
Why?
|
| Risperidone | 1 | 2003 | 48 | 0.220 |
Why?
|
| Depressive Disorder, Major | 2 | 2005 | 438 | 0.220 |
Why?
|
| Psychotherapy | 1 | 2005 | 253 | 0.210 |
Why?
|
| Psychiatric Status Rating Scales | 11 | 2000 | 782 | 0.210 |
Why?
|
| Fluoxetine | 3 | 1998 | 40 | 0.210 |
Why?
|
| Receptors, Dopamine | 9 | 1984 | 119 | 0.200 |
Why?
|
| Caudate Nucleus | 6 | 1984 | 56 | 0.200 |
Why?
|
| Absenteeism | 1 | 2001 | 27 | 0.200 |
Why?
|
| 1-Naphthylamine | 2 | 1998 | 11 | 0.200 |
Why?
|
| Efficiency | 1 | 2001 | 49 | 0.200 |
Why?
|
| Paroxetine | 2 | 1998 | 28 | 0.200 |
Why?
|
| Brain | 8 | 2004 | 2175 | 0.190 |
Why?
|
| Disability Evaluation | 1 | 2003 | 298 | 0.190 |
Why?
|
| Delivery of Health Care | 2 | 2003 | 445 | 0.190 |
Why?
|
| Anxiety | 2 | 2004 | 422 | 0.180 |
Why?
|
| Carbamazepine | 3 | 1989 | 108 | 0.170 |
Why?
|
| Affect | 2 | 1999 | 218 | 0.170 |
Why?
|
| Primary Health Care | 1 | 2005 | 702 | 0.170 |
Why?
|
| Behavioral Symptoms | 1 | 1999 | 32 | 0.170 |
Why?
|
| Magnetics | 1 | 1999 | 52 | 0.170 |
Why?
|
| Faculty, Medical | 2 | 1998 | 110 | 0.160 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1998 | 22 | 0.160 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 1998 | 17 | 0.160 |
Why?
|
| Alcoholism | 3 | 1999 | 1109 | 0.150 |
Why?
|
| Emotions | 1 | 1999 | 244 | 0.150 |
Why?
|
| Patient Readmission | 1 | 1999 | 267 | 0.150 |
Why?
|
| Comorbidity | 4 | 2003 | 1425 | 0.140 |
Why?
|
| Basal Ganglia Diseases | 2 | 2000 | 13 | 0.130 |
Why?
|
| Anxiety Disorders | 2 | 1998 | 426 | 0.130 |
Why?
|
| Anti-Anxiety Agents | 2 | 1986 | 107 | 0.130 |
Why?
|
| Electric Stimulation Therapy | 3 | 2001 | 147 | 0.120 |
Why?
|
| Female | 26 | 2005 | 38015 | 0.120 |
Why?
|
| Aged | 14 | 2005 | 14842 | 0.120 |
Why?
|
| Diagnosis, Differential | 6 | 2000 | 1139 | 0.120 |
Why?
|
| Neoplasms | 1 | 2005 | 1660 | 0.110 |
Why?
|
| Hospitalization | 6 | 1991 | 977 | 0.110 |
Why?
|
| Vietnam | 2 | 2005 | 36 | 0.110 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 1992 | 1 | 0.110 |
Why?
|
| Parasympatholytics | 2 | 1991 | 19 | 0.110 |
Why?
|
| Adolescent | 10 | 2005 | 8903 | 0.100 |
Why?
|
| Education, Medical, Graduate | 2 | 2006 | 214 | 0.100 |
Why?
|
| Alprazolam | 2 | 1988 | 35 | 0.100 |
Why?
|
| South Carolina | 5 | 2006 | 2750 | 0.100 |
Why?
|
| Psychiatric Nursing | 1 | 1991 | 33 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2005 | 378 | 0.100 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1990 | 25 | 0.100 |
Why?
|
| Electromagnetic Fields | 2 | 2001 | 66 | 0.100 |
Why?
|
| Thyrotropin | 1 | 1990 | 49 | 0.090 |
Why?
|
| Psychotropic Drugs | 1 | 1991 | 83 | 0.090 |
Why?
|
| Chronic Disease | 3 | 2000 | 1329 | 0.090 |
Why?
|
| Curriculum | 2 | 2006 | 575 | 0.090 |
Why?
|
| Corticosterone | 3 | 1988 | 51 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2000 | 1851 | 0.090 |
Why?
|
| Placebos | 2 | 2003 | 195 | 0.090 |
Why?
|
| Violence | 1 | 1991 | 275 | 0.090 |
Why?
|
| Metoclopramide | 1 | 1988 | 21 | 0.080 |
Why?
|
| Lithium | 4 | 1990 | 76 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2005 | 2264 | 0.080 |
Why?
|
| Double-Blind Method | 5 | 2003 | 1737 | 0.080 |
Why?
|
| Dystonia | 1 | 1988 | 18 | 0.080 |
Why?
|
| United States | 5 | 2005 | 7335 | 0.080 |
Why?
|
| Pituitary-Adrenal Function Tests | 1 | 1988 | 1 | 0.080 |
Why?
|
| Infusions, Intravenous | 3 | 1995 | 334 | 0.080 |
Why?
|
| Sertraline | 2 | 1998 | 62 | 0.080 |
Why?
|
| Cognition Disorders | 3 | 2000 | 342 | 0.080 |
Why?
|
| Benzodiazepines | 2 | 1986 | 130 | 0.080 |
Why?
|
| Teaching | 3 | 2001 | 169 | 0.080 |
Why?
|
| Cattle | 8 | 1984 | 475 | 0.070 |
Why?
|
| Tetrahydronaphthalenes | 2 | 1983 | 20 | 0.070 |
Why?
|
| Management Information Systems | 1 | 2006 | 4 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2005 | 2798 | 0.070 |
Why?
|
| Research | 2 | 1998 | 214 | 0.070 |
Why?
|
| Trazodone | 1 | 1985 | 5 | 0.070 |
Why?
|
| Acute Disease | 4 | 1988 | 658 | 0.070 |
Why?
|
| Desipramine | 1 | 1985 | 47 | 0.070 |
Why?
|
| Terminally Ill | 1 | 2005 | 17 | 0.060 |
Why?
|
| Prefrontal Cortex | 2 | 2001 | 639 | 0.060 |
Why?
|
| Urea | 1 | 2004 | 51 | 0.060 |
Why?
|
| Kinetics | 5 | 1984 | 1047 | 0.060 |
Why?
|
| Administration, Oral | 3 | 1995 | 411 | 0.060 |
Why?
|
| Professional-Patient Relations | 1 | 2005 | 71 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1985 | 150 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 1985 | 138 | 0.060 |
Why?
|
| Life Change Events | 1 | 2005 | 223 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2006 | 502 | 0.060 |
Why?
|
| Naphthalenes | 1 | 1983 | 47 | 0.060 |
Why?
|
| Speech | 1 | 2004 | 118 | 0.060 |
Why?
|
| Phobic Disorders | 1 | 2004 | 227 | 0.060 |
Why?
|
| Piperazines | 1 | 1985 | 206 | 0.060 |
Why?
|
| Substance-Related Disorders | 2 | 1991 | 1241 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 1988 | 106 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1983 | 60 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 306 | 0.060 |
Why?
|
| Physician Impairment | 1 | 1982 | 3 | 0.060 |
Why?
|
| Synaptic Membranes | 1 | 1982 | 8 | 0.050 |
Why?
|
| Social Problems | 1 | 1982 | 13 | 0.050 |
Why?
|
| Communication | 1 | 2005 | 329 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2006 | 596 | 0.050 |
Why?
|
| Edetic Acid | 1 | 1982 | 29 | 0.050 |
Why?
|
| Radioimmunoassay | 4 | 1988 | 164 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 1982 | 45 | 0.050 |
Why?
|
| Drug Therapy, Combination | 6 | 1991 | 648 | 0.050 |
Why?
|
| Patient Compliance | 2 | 2000 | 402 | 0.050 |
Why?
|
| MMPI | 1 | 2002 | 40 | 0.050 |
Why?
|
| Antidepressive Agents | 3 | 1990 | 216 | 0.050 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2003 | 257 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2003 | 7028 | 0.050 |
Why?
|
| Sick Leave | 1 | 2001 | 6 | 0.050 |
Why?
|
| Data Collection | 1 | 2003 | 420 | 0.050 |
Why?
|
| Age Factors | 3 | 2000 | 1860 | 0.050 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2001 | 69 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 1981 | 60 | 0.050 |
Why?
|
| Hospitals, Veterans | 1 | 2001 | 147 | 0.050 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1981 | 109 | 0.050 |
Why?
|
| Ambulatory Care | 2 | 1995 | 339 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 1982 | 188 | 0.050 |
Why?
|
| Prevalence | 1 | 2005 | 1609 | 0.050 |
Why?
|
| Dyskinesia, Drug-Induced | 2 | 1991 | 21 | 0.050 |
Why?
|
| Risk Factors | 3 | 1999 | 5719 | 0.050 |
Why?
|
| Psychological Tests | 1 | 2000 | 96 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2000 | 40 | 0.040 |
Why?
|
| Fluphenazine | 1 | 1999 | 19 | 0.040 |
Why?
|
| Drug Combinations | 3 | 2004 | 304 | 0.040 |
Why?
|
| Treatment Refusal | 1 | 1999 | 40 | 0.040 |
Why?
|
| Drug Costs | 1 | 2000 | 87 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 1999 | 67 | 0.040 |
Why?
|
| Ejaculation | 1 | 1998 | 3 | 0.040 |
Why?
|
| Orgasm | 1 | 1998 | 3 | 0.040 |
Why?
|
| Libido | 1 | 1998 | 7 | 0.040 |
Why?
|
| Penile Erection | 1 | 1998 | 18 | 0.040 |
Why?
|
| Marketing of Health Services | 1 | 1998 | 18 | 0.040 |
Why?
|
| Staff Development | 1 | 1998 | 35 | 0.040 |
Why?
|
| Medicine | 1 | 1998 | 51 | 0.040 |
Why?
|
| Organizational Culture | 1 | 1998 | 59 | 0.040 |
Why?
|
| Specialization | 1 | 1998 | 66 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 546 | 0.040 |
Why?
|
| Reference Values | 1 | 1999 | 579 | 0.040 |
Why?
|
| Consumer Behavior | 1 | 1998 | 68 | 0.040 |
Why?
|
| Aporphines | 3 | 1981 | 5 | 0.040 |
Why?
|
| Seizures | 1 | 2000 | 279 | 0.040 |
Why?
|
| Health Resources | 1 | 1998 | 76 | 0.040 |
Why?
|
| Patient Care | 1 | 1998 | 61 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 1998 | 61 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 1998 | 149 | 0.040 |
Why?
|
| Survivors | 1 | 1999 | 254 | 0.040 |
Why?
|
| In Vitro Techniques | 5 | 1984 | 765 | 0.030 |
Why?
|
| Personnel Management | 1 | 1995 | 11 | 0.030 |
Why?
|
| Sex Factors | 1 | 2000 | 1265 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 1999 | 251 | 0.030 |
Why?
|
| Length of Stay | 1 | 1999 | 780 | 0.030 |
Why?
|
| False Positive Reactions | 2 | 1988 | 95 | 0.030 |
Why?
|
| Binding, Competitive | 4 | 1983 | 165 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 1999 | 413 | 0.030 |
Why?
|
| Community Mental Health Services | 1 | 1995 | 65 | 0.030 |
Why?
|
| Time Factors | 2 | 1998 | 4655 | 0.030 |
Why?
|
| Corpus Striatum | 5 | 1983 | 278 | 0.030 |
Why?
|
| Cocaine-Related Disorders | 1 | 1999 | 504 | 0.030 |
Why?
|
| Subcellular Fractions | 2 | 1984 | 92 | 0.030 |
Why?
|
| Health Services Research | 1 | 1995 | 209 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 4843 | 0.030 |
Why?
|
| Prospective Studies | 3 | 1998 | 3702 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1995 | 567 | 0.030 |
Why?
|
| Tritium | 2 | 1983 | 101 | 0.030 |
Why?
|
| Mestranol | 1 | 1992 | 1 | 0.030 |
Why?
|
| Norethindrone | 1 | 1992 | 1 | 0.030 |
Why?
|
| Ethinyl Estradiol-Norgestrel Combination | 1 | 1992 | 1 | 0.030 |
Why?
|
| Norgestrel | 1 | 1992 | 2 | 0.030 |
Why?
|
| Ethinyl Estradiol | 1 | 1992 | 3 | 0.030 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1992 | 6 | 0.030 |
Why?
|
| Binding Sites | 2 | 1984 | 631 | 0.030 |
Why?
|
| Adenylyl Cyclases | 5 | 1983 | 94 | 0.030 |
Why?
|
| Animals | 11 | 1984 | 20877 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 1983 | 420 | 0.030 |
Why?
|
| Drug Interactions | 2 | 1990 | 289 | 0.030 |
Why?
|
| Depression | 1 | 1999 | 942 | 0.030 |
Why?
|
| Benztropine | 1 | 1991 | 2 | 0.030 |
Why?
|
| Patient Isolation | 1 | 1991 | 35 | 0.030 |
Why?
|
| Quality of Life | 1 | 2000 | 1515 | 0.020 |
Why?
|
| Psychiatric Department, Hospital | 1 | 1991 | 17 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 1991 | 70 | 0.020 |
Why?
|
| Hospitals, Psychiatric | 1 | 1991 | 59 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 1991 | 59 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 1991 | 108 | 0.020 |
Why?
|
| Cell Membrane | 2 | 1983 | 523 | 0.020 |
Why?
|
| Nortriptyline | 1 | 1990 | 28 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2001 | 137 | 0.020 |
Why?
|
| Dopamine | 2 | 1982 | 474 | 0.020 |
Why?
|
| Clinical Competence | 2 | 2006 | 657 | 0.020 |
Why?
|
| Duodenal Ulcer | 1 | 1988 | 16 | 0.020 |
Why?
|
| Monoamine Oxidase | 2 | 1986 | 26 | 0.020 |
Why?
|
| Mathematics | 1 | 1988 | 83 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1988 | 79 | 0.020 |
Why?
|
| Methylene Blue | 1 | 1987 | 16 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 1988 | 218 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1991 | 1753 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 1999 | 7264 | 0.020 |
Why?
|
| Mood Disorders | 1 | 1988 | 132 | 0.020 |
Why?
|
| Incidence | 1 | 1991 | 1582 | 0.020 |
Why?
|
| Integrated Advanced Information Management Systems | 1 | 2006 | 2 | 0.020 |
Why?
|
| Depression, Chemical | 1 | 1986 | 29 | 0.020 |
Why?
|
| Professional Staff Committees | 1 | 2006 | 11 | 0.020 |
Why?
|
| Rats | 7 | 1983 | 5300 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 1986 | 31 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2006 | 53 | 0.020 |
Why?
|
| Systems Integration | 1 | 2006 | 30 | 0.020 |
Why?
|
| Social Responsibility | 1 | 2006 | 39 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2006 | 70 | 0.020 |
Why?
|
| Accreditation | 1 | 2006 | 72 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1985 | 45 | 0.020 |
Why?
|
| Cocaine | 1 | 1991 | 555 | 0.020 |
Why?
|
| Anorexia Nervosa | 1 | 1986 | 52 | 0.020 |
Why?
|
| Lithium Carbonate | 1 | 1985 | 31 | 0.020 |
Why?
|
| Biopharmaceutics | 1 | 1984 | 5 | 0.020 |
Why?
|
| Peroxides | 1 | 2004 | 23 | 0.020 |
Why?
|
| Clinical Trials as Topic | 3 | 1999 | 848 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 1985 | 36 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1985 | 219 | 0.020 |
Why?
|
| Sleep, REM | 1 | 1985 | 93 | 0.020 |
Why?
|
| Dominance, Cerebral | 2 | 2001 | 65 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1988 | 435 | 0.020 |
Why?
|
| Paranoid Disorders | 1 | 1983 | 9 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1985 | 284 | 0.010 |
Why?
|
| Software | 1 | 2006 | 418 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1983 | 63 | 0.010 |
Why?
|
| Probability | 1 | 1983 | 244 | 0.010 |
Why?
|
| Phenethylamines | 1 | 1981 | 20 | 0.010 |
Why?
|
| Algorithms | 1 | 1988 | 1194 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2004 | 531 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1982 | 182 | 0.010 |
Why?
|
| Sleep Wake Disorders | 1 | 1982 | 94 | 0.010 |
Why?
|
| Suicide | 1 | 1982 | 115 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 689 | 0.010 |
Why?
|
| Psychiatry | 1 | 1982 | 112 | 0.010 |
Why?
|
| Feeding and Eating Disorders | 1 | 1982 | 106 | 0.010 |
Why?
|
| Electroconvulsive Therapy | 1 | 1985 | 402 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1548 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2001 | 168 | 0.010 |
Why?
|
| Prognosis | 1 | 1985 | 2093 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 1982 | 261 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 1999 | 57 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1982 | 383 | 0.010 |
Why?
|
| Program Development | 1 | 2001 | 240 | 0.010 |
Why?
|
| Smoking | 1 | 1988 | 1449 | 0.010 |
Why?
|
| Limbic System | 1 | 1999 | 106 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2001 | 333 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1999 | 156 | 0.010 |
Why?
|
| Chemical Phenomena | 3 | 1982 | 62 | 0.010 |
Why?
|
| Chemistry | 3 | 1982 | 45 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2004 | 824 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1982 | 1745 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1999 | 296 | 0.010 |
Why?
|
| Opioid-Related Disorders | 1 | 1982 | 298 | 0.010 |
Why?
|
| Economics, Medical | 1 | 1995 | 8 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 1995 | 14 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 2222 | 0.010 |
Why?
|
| Health Care Reform | 1 | 1995 | 62 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1985 | 2323 | 0.010 |
Why?
|
| Cyclic AMP | 2 | 1986 | 223 | 0.010 |
Why?
|
| Health Policy | 1 | 1995 | 221 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1995 | 503 | 0.010 |
Why?
|
| Stereotyped Behavior | 2 | 1983 | 42 | 0.010 |
Why?
|
| Stereoisomerism | 2 | 1983 | 169 | 0.010 |
Why?
|
| Radioligand Assay | 2 | 1983 | 109 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1991 | 107 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1990 | 142 | 0.010 |
Why?
|
| Child Behavior Disorders | 1 | 1989 | 69 | 0.010 |
Why?
|
| Child | 2 | 1989 | 6400 | 0.000 |
Why?
|
| Hyperphagia | 1 | 1986 | 7 | 0.000 |
Why?
|
| Sexual Maturation | 1 | 1986 | 10 | 0.000 |
Why?
|
| Phenelzine | 1 | 1983 | 7 | 0.000 |
Why?
|
| Doxepin | 1 | 1983 | 5 | 0.000 |
Why?
|
| Amitriptyline | 1 | 1983 | 11 | 0.000 |
Why?
|
| Imipramine | 1 | 1983 | 44 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1983 | 57 | 0.000 |
Why?
|
| Circular Dichroism | 1 | 1983 | 99 | 0.000 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1982 | 5 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1983 | 532 | 0.000 |
Why?
|
| Reserpine | 1 | 1982 | 24 | 0.000 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 1982 | 29 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1983 | 381 | 0.000 |
Why?
|
| Spiperone | 1 | 1981 | 29 | 0.000 |
Why?
|
| Synaptosomes | 1 | 1982 | 57 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1989 | 3185 | 0.000 |
Why?
|
| Molecular Conformation | 1 | 1982 | 128 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1982 | 198 | 0.000 |
Why?
|
| Phenoxybenzamine | 1 | 1980 | 7 | 0.000 |
Why?
|
| Models, Molecular | 1 | 1983 | 546 | 0.000 |
Why?
|
| Motor Activity | 1 | 1983 | 621 | 0.000 |
Why?
|